News | September 23, 2024
Fermenta Biotech receives EU GMP Certification for its Dahej facility
This approval reflects company’s unwavering commitment that the quality assurance
This approval reflects company’s unwavering commitment that the quality assurance
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Subscribe To Our Newsletter & Stay Updated
